Preferred Label : Triosephosphate isomerase deficiency;
Symbol : TPID;
CISMeF acronym : TPID;
Type : Phenotype, molecular basis known;
Description : Triosephosphate isomerase (TPI) deficiency is an autosomal recessive multisystem disorder
characterized by congenital hemolytic anemia, progressive neuromuscular dysfunction,
susceptibility to bacterial infection, and cardiomyopathy. Homozygotes exhibit markedly
reduced enzyme activity in all tissues studied, accompanied by metabolic block in
glycolysis with intracellular accumulation of dihydroxyacetonephosphate (DHAP), particularly
in red blood cells, which lack the capacity to metabolize DHAP in the glycerophosphate
shuttle via alpha-glycerophosphate dehydrogenase. Heterozygotes have approximately
50% normal TPI activity, but manifest no evidence of metabolic block or clinical effects,
implying that this level of enzyme activity is sufficient to maintain normal metabolic
function (summary by Ationu et al., 1999).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the triosephosphate isomerase-1 gene (TPI1, 190450.0001);
Laboratory abnormalities : Increased levels of dihydroxyacetone phosphate (DHAP) in tissues and red cells; Decreased activity of triosephosphate isomerase;
Prefixed ID : #615512;
Origin ID : 615512;
UMLS CUI : C1860808;
- Currated CISMeF NLP mapping
- DO Cross reference
- Genes related to phenotype
- HPO term(s)
- ORDO concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT